CollPlant Biotechnologies (CLGN) Cost of Revenue (2017 - 2026)
CollPlant Biotechnologies (CLGN) posted Cost of Revenue of $316000.0 for Q1 2026, up 64.58% on a QoQ basis from $192000.0 in Q4 2025, and up 68.09% year-over-year from $188000.0 in Q1 2025.
CollPlant Biotechnologies (CLGN) Cost of Revenue (2017 - 2026) Analysis & Trends
CollPlant Biotechnologies' Cost of Revenue history runs 10 years deep, the most recent figure standing at $316000.0 for Q1 2026.
- Quarterly Cost of Revenue rose 68.09% year-over-year to $316000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $963000.0 (down 24.05% YoY) and the FY2025 annual result came in at $835000.0, down 48.62% from the prior year.
- Cost of Revenue was $316000.0 for Q1 2026 at CollPlant Biotechnologies, up from $192000.0 in the prior quarter.
- Across five years, Cost of Revenue topped out at $773000.0 in Q4 2023 and bottomed at $31000.0 in Q1 2022.
- A 5-year average of $303941.2 and a median of $272000.0 in 2024 frame the typical range for Cost of Revenue.
- Annual changes were most pronounced in 2022 — Cost of Revenue plunged 96.5% — and 2023, when it soared 1330.23%.
- CollPlant Biotechnologies' Cost of Revenue stood at $62000.0 in 2022, then soared by 1146.77% to $773000.0 in 2023, then tumbled by 64.81% to $272000.0 in 2024, then fell by 29.41% to $192000.0 in 2025, then jumped by 64.58% to $316000.0 in 2026.
- Business Quant data shows CLGN's Cost of Revenue at $316000.0 in Q1 2026, $192000.0 in Q4 2025, and $269000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 167.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 392.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 296.00 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 145.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 | 316,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 30, 2026 | 316,000.00 |
| Mar 30, 2026 | 316,000.00 |
| Dec 31, 2025 | 192,000.00 |
| Dec 31, 2025 | 192,000.00 |
| Sep 30, 2025 | 269,000.00 |
| Sep 30, 2025 | 269,000.00 |
| Jun 30, 2025 | 186,000.00 |
| Jun 30, 2025 | 186,000.00 |
| Mar 30, 2025 | 188,000.00 |
| Mar 30, 2025 | 188,000.00 |
| Dec 31, 2024 | 272,000.00 |
| Dec 31, 2024 | 272,000.00 |
| Sep 30, 2024 | 272,000.00 |
| Sep 30, 2024 | 272,000.00 |
| Jun 30, 2024 | 536,000.00 |
| Jun 30, 2024 | 536,000.00 |
| Mar 31, 2024 | 545,000.00 |
| Mar 31, 2024 | 545,000.00 |
| Dec 31, 2023 | 773,000.00 |
| Dec 31, 2023 | 773,000.00 |